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This work presents the development and validation of a quantitative HILIC UHPLC-ESI-
QTOF-MS/MS method for amino acids combined with untargeted metabolic profiling of 
human corneal epithelial (HCE) cells after treatment with ionic liquids. The work included 
a preliminary metabotoxicity screening of 14 different ionic liquids, of which 9 carefully 
selected ionic liquids were chosen for a metabolomics study. This study is focused on 
the correlation between the toxicity of the ionic liquids and their metabolic profiles. The 
method development included the comparison of different MS/MS acquisition modes. A 
sequential window acquisition of all theoretical fragment ion mass spectra (SWATH) 
method with variable Q1 window widths and narrow Q1 target windows of 5 Da for most 
of the amino acids was selected as the optimal acquisition mode. Due to the absence of 
a true blank matrix, 13C,15N-isotopically labelled amino acids were utilized as surrogate 
calibrants, instead of proteinogenic amino acids. Partial least squares (PLS) analysis of 
the median effective concentrations (EC50) of 9 selected ionic liquids showed a 
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The industrial use of ionic liquids (ILs) as environmentally friendly solvents is steadily 
increasing [1,2]. Because of their structure, ILs are also called “molten salts” [3]. They have 
many unique characteristics, such as i) wide temperature range (incl. room temperature) of 
liquid state, ii) thermal, chemical and electrochemical stability, iii) high electrochemical 
conductivity. Since they are non-flammable, non-explosive, and non-volatile, they are used in 
many applications, also owing to their large range of solubilities and miscibilities. Their lack 
of biodegradability, however, renders toxicity studies imperative [4,5]. This matter is 
complicated because of the high structural variability and large number of existing ILs, 
requiring a differentiated picture of toxic effects of ILs [1,6,7]. One important future aspect is 
the structural design and development of environmentally friendly ILs. For this purpose, the 
understanding of toxic effects is of high importance, and effects of ILs on metabolic profiles 
might well serve as an indicator for their toxicity. Along this line, toxicometabolomics and 
toxicolipidomics could shed some light on effects of ILs [8,9].  
Such metabolomics studies could be either devised as targeted or untargeted assays. The 
former make typically use of UHPLC hyphenated to triple quadrupole instruments with 
electrospray ionization (UHPLC-ESI-QqQ) which has advantages in terms of sensitivity and 
linear range [9,10]. The latter use high-resolution mass spectrometry (HRMS) hyphenated to 
UHPLC and allow comprehensive recording of all detectable metabolites. However, the new 
generation of high-resolution mass spectrometers (QTOF and quadrupole-orbitraps) show 
improved performance for quantitative analysis [11,12]. Hence, there is an increasing interest 
in performing qualitative and quantitative analysis in a single run [11,13–16]. In general, 
HRMS-based untargeted metabolomics is typically performed by data-dependent acquisition 
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(DDA) (also called information-dependent acquisition, IDA). DDA methods use information 
from an MS scan for selection of the most abundant precursors for fragmentation being able 
to identify metabolites based on MS/MS spectra. Unfortunately, low abundant metabolites 
are not triggered for fragmentation [11,13,17–20]. Relative quantification is exclusively based 
on MS data which may be less sensitive. To overcome this shortcoming, data-independent 
acquisition (DIA) such as all-ion fragmentation (AIF), MSE, or MS/ MSALL has been proposed 
as an alternative [20,21]. This acquisition mode selects all precursor ions for simultaneous 
co-fragmentation. The resultant MS/MS spectra may be relatively complex composite 
spectra, if many compounds coelute [11,21]. Consequently, qualitative analysis of unknowns 
may be quite challenging by these classical DIA methods [20,22]. It has been shown that a 
better spectral quality data can be obtained with a DIA method called sequential window 
acquisition of all theoretical fragment ion mass spectra (SWATH) [17,19], an acquisition 
approach first proposed for linear ion trap [23]. In DIA with SWATH, a sequence of MS/MS 
experiments with intermediate wide Q1 precursor ion selection windows (SWATH windows) 
(typically 20-30 Da wide) are consecutively stepped through the targeted m/z range [11,22]. 
The resultant MS/MS spectra are less complex than in AIF or MSE, which facilitates 
identification. A broader metabolite coverage compared to DDA was reported [24,25]. Since 
MS/MS data have been collected comprehensively throughout the chromatogram, 
quantitative analysis can be performed on the MS/MS level as well, potentially leading to 
better sensitivity [23]. 
Amino acids are central cellular metabolites. For instance, they are important for protein 
synthesis, cell signalling, and redox balance [26]. Major perturbations may indicate problems 
with cellular homeostasis. Thus, in the current study amino acids were selected as surrogate 
biomarkers of cellular toxicity of ILs. Numerous HPLC-MS assays for targeted analysis of 
amino acids have been reported [27–29]. Many times, amino acids were derivatized prior to 
their analysis to improve detection sensitivity [30]. In the present work, the aim was to 
develop a fast and straightforward UHPLC-ESI-QTOF-MS/MS method which combines 
targeted analysis of amino acids without any derivatization and simultaneously allow 
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untargeted profiling of alterations in the metabolome. DIA with SWATH was used as the 
acquisition mode to realize this combined qualitative/quantitative assay. Human corneal 
epithelial (HCE) cells were employed as representative model cells. A wide variety of ILs 
were selected and the metabolic profiles measured after incubation of the HCE cells with ILs 
at concentration levels corresponding to their median effective concentration (EC50) values 
[4]. Here we will demonstrate that there is a correlation between the changes in the 
metabolic profiles and the toxicity of the ILs.  
2. Materials and methods 
2.1.  Materials and instruments 
Ultra-LC-MS grade acetonitrile was purchased from Carl Roth (Karlsruhe, Germany), MilliQ 
water was purified with an Elga PurLab Ultra purification system (Celle, Germany), 
ammonium formate was purchased from Sigma Aldrich (Munich, Germany), cell free amino 
acid mix (20AA, U-13C, 97-99%+; U-15N, 97-99%) and Metabolomics Amino Acid Mix 
Standard was purchased from Cambridge Isotope Laboratories (Tewksbury, MA ,USA). 13C2-
maleic acid and 13C6-glucose were purchased from Santa Cruz Biotechnology (Heidelberg, 
Germany), d8-L-valine, ring-d4-L-tyrosine, 3,3,4,4,5,5,6,6-d8-L-lysine·2HCl were purchased 
from Eurisotop (Saarbrücken, Germany). Phosphate buffered saline (PBS) was made “in-
house” by the National Institute of Health and Welfare (THL), Helsinki, Finland. Ham’s 
F12/Dulbecco’s modified eagle medium (DMEM), fetal bovine serum (FBS), human 
epidermal growth factor (EGF), insulin, and gentamicin were all purchased from Thermo-
Fisher Scientific (Waltham, MA, USA). Methanol and cholera toxin were purchased from 
Sigma (St. Louis, MO, USA). Cell incubator and centrifuges were from Thermo-Fisher 
Scientific (Waltham, MA, USA). Samples were ultrasonicated using Soniprep 150 from MSE 
(London, UK). Standard solutions were prepared as described in Suppl. Material. 
2.2. Cell culture and metabolite extraction 
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The SV-40 immortalized HCE cells [31] were grown in a 10cm petri dish until confluence (8.8 
x 106 cells) in Ham’s F12/DMEM supplemented with 15% FBS and EGF, insulin, cholera 
toxin and gentamicin. Before IL treatment, the cells were starved for 18 hours in serum free 
Ham’s F12/DMEM supplemented with EGF, insulin, cholera toxin, and gentamicin to achieve 
serum free conditions, eliminate serum growth factor and nutrient activities on the surface of 
the cells, and equalize all cells to the same cell cycle phase by stopping the cell growth. After 
starvation, the cells were incubated with different ILs (Figure 1) dissolved in serum free 
media to achieve concentrations around their EC50 values, determined by Ruokonen et al. 
[4]. After 8, 16, and 24h the petri dishes were placed directly on ice for quenching the 
enzyme activity immediately. The cell monolayer was washed twice with 5 to 7 mL cold PBS 
buffer before 600 µL of ice-cold extraction mix was added. The extraction mix composed of 
258 µL of MeOH, 300 µL of cell free amino acid mix (1 mg/mL), and 42 µL of ACN:H2O (1:1 
v/v). Next, the cells were scraped from the petri dish wall into the extraction mixture and the 
suspension of the cells was transferred into an Eppendorf tube. The suspension was 
ultrasonicated with a MSE Soniprep 150 probe ultrasonicator (10 sec, 23 MHz, pulse of 5-7 
microns) and centrifuged at 10 000 g for 5 minutes, and the supernatant separated from the 
cell pellet was stored at -80 °C until further analysis. 
2.3. LC-MS/MS instrumentation 
All analyses were performed on a Sciex TripleTOF 5600+ equipped with a Duospray ion 
source (Sciex, Concord, Ontario; Canada) and carried out with electrospray ionization (ESI) 
in positive ion mode. The mass spectrometer was coupled to an Agilent 1290 Series UHPLC 
instrument (Agilent, Waldbronn, Germany) with a Pal HTC-XS autosampler from CTC 
(Zwingen, Switzerland).  
The chromatographic HILIC separation was performed on an Acquity UPLC BEH Amide 
column (2.1 x 50 mm) packed with 1.7 µm particles (Waters, Eschborn) equipped with an 
Acquity UPLC BEH Amide 1.7 µm Van-guard column. The mobile phase composed of A) 10 
mM ammonium formate in MilliQ water with 0.15 % (v/v) formic acid adjusted to pH 3 and B) 
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2 mM ammonium formate in ACN with 0.15 % (v/v) formic acid. The following mobile phase 
gradient was used: 0.00 – 0.50 min, 95 % B; 0.50 – 0.51 min, 95 – 90 % B; 0.51 – 8.00 min, 
90 – 70 % B; 8.00 – 10.00 min, 70 % B; 10.00 – 10.01 min, 70 – 95 % B; 10.01 – 12.00 min, 
95 % B. The flow rate was 300 µL/min and the column temperature was set at 40 °C. The 
injection volume was 2 µL for all measurements.  
The following MS settings of the mass spectrometer were identical for all four investigated 
acquisition modes: Curtain gas (CUR) 20 psi, nebulizer gas (GS1) 60 psi, drying gas (GS2) 
60 psi, ion-spray voltage floating (ISVF) +4000 V and source temperature (T) 500 °C. 
Nitrogen was used as curtain gas, nebulizer gas and drying gas. 
High-resolution MS and high-sensitivity MS/MS data for the amino acid mixture containing all 
20 proteinogenic amino acids, were acquired by three different acquisition modes: MRMHR, 
SWATH with fixed Q1 window widths and SWATH with variable Q1 window widths (SWATH 
2.0) (for details see Suppl. Material). An external calibration was performed every five 
samples.  
For the finally used method, SWATH acquisition mode with variable window widths was 
utilized. It consisted of a TOF-MS scan (collision energy CE 10 V, declustering potential DP 
30 V, cycle time CT 1.3 s, accumulation time AT 200 ms, SW m/z 30–1000 and RF m/z 20 
33 %, m/z 70 33 %, m/z 270 34 %) and several different product ion scans with individual CE 
and DP settings (Table 1). The product ion scans consisted of 27 Q1 windows with different 
window widths in the mass range of 30–300 m/z (Table 1). 
2.4. Calibration and validation 
2.4.1. Matrix effect 
The matrix effect (ME) can be determined by calculating the ratios of slopes of calibration 
functions in presence and absence of matrix components, i.e. post-extraction spike of 
surrogate calibrants and neat standard solution of surrogate calibrants, according to eq. 1.  
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      (eq. 1) 
Therefore, the 13C,15N-isotopically labelled amino acids were diluted with ACN:MilliQ water 
(1:1; v:v) to achieve the same dilutions as described in SI 4. Response factors. The same 
serial dilutions were prepared in a HCE cell extract (not treated with ILs). Deuterated amino 
acids were used as internal standards. 
 
2.4.2. Calibration 
13C,15N-L-amino acids were used as surrogate calibrants for calibration and validation. The 
surrogate calibration was prepared in a matrix-matched manner. Different amounts of 
13C,15N-amino acid standard mixture were spiked into an untreated HCE cell extract to 
prepare dilutions of 1:10; 1:20; 1:40; 1:160; 1:640; 1:1000; 1:4000; 1:16 000; 1:64 000 and 
1:250 000. The HCE extract itself was finally diluted by a factor of 10 with ACN:MilliQ water 
(1:1; v:v) in all calibration solutions. Deuterated amino acids were used as internal standards. 
The dilution series in cell extract matrix was measured four times. The calibration functions 
were obtained by plotting peak area ratios versus concentrations of the 13C,15N-isotopically 
labelled amino acids. Based on these functions, unweighted linear regression functions were 
constructed using the MultiQuant software. These calibration functions were used for the 
quantification of amino acids in treated HCE cell extracts taking the response factors (RF; 
see Suppl. Material for details) into account according to eq. 2 where a is the slope and b is 
the intercept of the calibration function of the 13C,15N-isotopically labelled amino acids. 
                     
                                        
 




The validation process comprising intra-day and inter-day precision and accuracy as well as 
freeze-thaw stability measurements was carried out by measuring quality control (QC) 
samples. These, were prepared by spiking different amounts of 13C,15N-isotopically labelled 
amino acid mixture to untreated HCE cell extracts at different levels across the entire range. 
The deuterated amino acids 3,3,4,4,5,5,6,6-d8-L-Lys 2HCl (5 µg/mL), ring-d4-L-Tyr (250 
ng/mL), and d8-L-Val (16 ng/mL) were used as internal standards. Eight different QC 
samples were prepared by dilution (1:12.5; 1:25; 1:100; 1:400; 1:800; 1:2000; 1:10 000 and 
1:100 000) of the 13C,15N-isotopically labelled amino acids spiked HCE cell extracts with 
ACN:MilliQ water (1:1, v:v). The HCE cell extracts were finally diluted to 1:10 (% v/v) in all 
QC samples. The inter-day precision and accuracy were determined with n=8 at three 
different days within a week (day 1, 3, and 4) with a calibration series at the beginning and 
the end of the measurement sequence. Intra-day precisions and accuracies were calculated 
separately every single day.  
The QC samples for the freeze-thaw stability test were frozen and thawed according to 
recommendations by the U.S. Food and Drug Administration (FDA) guidelines on 
bioanalytical method validation. The samples were measured four times and autosampler 
stability was verified on day four of the validation by measuring the calibration calibrants 
according to the FDA guidelines. 
2.5. Data processing of untargeted analysis 
Raw data (.wiff) files were converted to .abf files for using MS-Dial (version 2.80) with a 
combination of MassBank, MoNA, ReSpect, and GNPS databases. The MS-Dial software 
was used for peak alignment, peak detection, peak identification, and deconvolution [24,25]. 
The used parameters for MS-Dial are listed in detail in SI Table S4. Multivariate statistical 
evaluation of the preprocessed metabolic profiling data was performed with SIMCA-P+ 
(version12) (Umetrics, Umeå, Sweden). The signal intensity data were log transformed, 
scaled (Pareto), and finally a Partial least squares (PLS) analysis was carried out using log 
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EC50 values as the dependent (Y) variables and all the molecular features as X-variables. 
The heatmap was generated with Perseus and the data were scaled to z-score. 
3. Results and discussion 
3.1. Chromatographic conditions 
Several common HILIC columns were screened initially and BEH Amide (1.7 µm) was finally 
selected for further optimization of the gradient profile, column temperature (30-60 °C), and 
flow rate (250-700 µL/min). The prime focus of these experiments was to achieve a 
separation of the amino acid pairs Leu/Ile, Asn/Asp, and Gln/Glu. Furthermore, the aim was 
to keep run times short at sufficient resolution of metabolites to reduce ion suppression 
(matrix) effects. A temperature of 40 °C and a flow rate of 300 µL/min were selected as a 
best compromise between a reasonable separation of the amino acids and good sensitivities 
(i.e., better signal-to-noise, S/N). Figure 2 shows the MS/MS chromatograms (MS 
chromatogram in case of Gly) of the 20 proteinogenic amino acids obtained the with 
optimized HILIC method. The amino acids were widely spread over the chromatogram 
between 3 and 9 min. The isomeric amino acids leucine and isoleucine were fully separated, 
like the critical amino acid pairs Glu/Gln and Asn/Asp. Some peak tailing was observed for 
amino acids with basic side chains and aspartic acid. Such peak tailing can be reduced by 
using higher buffer concentrations at expense of signal intensity loss which was therefore not 
implemented. 
3.2. Mass spectrometry settings and acquisition mode 
The adopted acquisition mode should allow sensitive detection of the targeted compounds 
and, on the other hand, a molecular profiling without prior knowledge of the molecular 
structure of sample components. One option is to utilize product ion scans (termed MRMHR) 
with unit mass Q1 precursor selection for fragmentation and HR-MS/MS spectra readout by 
the TOF mass analyzer. It allows comprehensive untargeted profiling in MS mode while 
additionally for preselected targets MS/MS spectra are recorded throughout the 
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chromatogram. Therefore, MS/MS chromatograms (EICs) can be generated for the targeted 
compounds. These EICs are benefiting from the effective filtering of the background noise 
and the narrow isolation windows (usually 5-10 mDa wide). Unfortunately, for untargeted 
molecules no MS/MS data are available if this acquisition mode is selected. This limits 
identification and metabolite coverage. Since DDA provides MS/MS spectra for the most 
abundant precursors only and does not allow to extract MS/MS-chromatograms, we decided 
to evaluate DIA with SWATH in comparison to MRMHR (parameters see Suppl. Table S1) as 
data acquisition mode. 
SWATH combines features of targeted and untargeted profiling assays. Each MS cycle in 
this acquisition mode consisted of a TOF MS scan over a predefined m/z, herein m/z 30-300, 
followed by a series of MS/MS experiments covering the entire m/z range by a set of 
sequential intermediate-sized Q1 precursor isolation windows (SWATH windows). Two 
distinct SWATH methods were compared: One with fixed SWATH windows which consisted 
of 27 MS/MS experiments each with 10 Da Q1 isolation width (SWATH with fixed Q1 
windows; see SI Table S2 and SI Figure S1). A second method made use of variable Q1 
precursor isolation windows which were narrower for the targeted precursors (e.g. 2-5 Da 
wide; one to four amino acids per SWATH window) and wider for other m/z ranges (SWATH 
with variable window approach; SWATH 2.0, see Table 1 and SI Figure S1). Co-eluting 
compounds which are co-isolated in the same SWATH window for fragmentation yield 
composite spectra. Hence, MS/MS spectra quality may be worse than in DDA, but 
deconvolution may remove contaminating ions leading to reasonable spectral quality. In the 
variable SWATH window approach, assay specificity can be adjusted by selection of narrow 
Q1 windows for targets. The great benefit of these SWATH methods is that MS/MS data are 
acquired comprehensively across the peak, over the entire chromatogram and across all 
samples. This enables post acquisition selection of the most suitable ion (precursor from 
MS1, precursor from MS2 if available, or any fragment ion from MS2) for signal processing 
and data evaluation whichever is more selective and/or more sensitive. In this combined 
targeted/untargeted assay, ion source and fragmentation parameters were optimized for the 
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targeted amino acids (for MRMHR method see SI Table S1, for SWATH with fixed Q1 
windows approach see SI Table S2 and for the finally selected SWATH with variable Q1 
windows approach, denoted SWATH 2.0, see Table 1). For each SWATH window CE and 
DP can be set individually to achieve the highest sensitivity for the target masses of interest. 
The three acquisition modes mentioned above were compared to each other. The relative 
peak areas of the amino acid fragment masses having the same concentration were 
evaluated with MultiQuant software. The measured concentrations of the neat amino acid 
standard mixtures are listed in SI Table S3. The comparison in Figure S2, however, is based 
on the lowest measured concentration of each amino acid (i.e. concentration level 8), except 
for L-Cys (640 ng/mL), L-Asp (400 ng/mL), and L-Met (6.4 ng/mL). Figure S2 shows the 
results normalized to the peak areas of MRMHR. The column chart clearly visualizes the 
sensitivity improvement of SWATH 2.0 (SWATH with variable Q1 windows) compared to 
SWATH (SWATH with fixed Q1 windows) and MRMHR. Since most of the SWATH 2.0 
windows contained only one target amino acid, the target-optimized CEs and DPs could be 
transferred from MRMHR to the respective SWATH windows. In this context, it is interesting to 
note that, in spite of identical CE, DP, and accumulation times, the sensitivities of the 
SWATH method with variable windows was better than with MRMHR. With fixed SWATH 
windows of 10 Da, a compromise in CE/DP had to be accepted for many amino acids 
because several of these targets were isolated in the same SWATH window (see SI Table 
S2) causing lower sensitivity. SWATH with variable Q1 windows was therefore selected as 
acquisition mode for the further work and MS settings optimized for each window. 
With the optimized SWATH method (Table 1) peak group chromatograms, i.e., series of 
overlapping MS/MS chromatograms as exemplified in Figure 3A, can be obtained for both 
targeted as well as untargeted metabolites due to comprehensive MS/MS data. The 
corresponding MS/MS spectra as measured in standard solution, HCE cell extract, and the 
deconvoluted MS/MS spectra with database match are shown in Figure 3B, 3C, and 3D, 
respectively. MS/MS spectra and peak group chromatograms of all the other target amino 
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acids are shown in SI Figure S3 and S4, respectively. MRMHR offers this possibility only for 
the previously selected targets, but not for the untargeted metabolites. Examples of MS/MS 
chromatograms of untargeted metabolites are depicted in Figures 4A and 4B along with 
corresponding MS/MS spectra in standard solution, HCE extract and deconvoluted ones 
from HCE extract (Fig. 4C, 4D and 4E). 
The most intensive signal (and/or the one with suitable assay specificity) was then selected 
post-acquisition for quantitative analysis of the targets (Table 2) while other signals were 
used as qualifiers for verification. Table 2 shows S/N ratios (calculated by PeakView 
software) for distinct EICs from a HCE cell extract measured using SWATH 2.0 (with variable 
Q1 windows). The S/N ratios are based on EICs for either the precursor ion in MS or MS/MS 
experiment or the fragment ion in the MS/MS experiment. As can be seen, the MS/MS 
signals are by far more sensitive (best S/N always obtained with fragment ion in the 
corresponding SWATH window except for Gly and Pro for which the precursor ion in the 
corresponding SWATH window gave higher S/N) (Table 2). 
3.3. Method calibration and validation 
Due to significant endogenic amino acid levels in HCE cells, no blank matrix was available 
for calibration and validation. Working with an artificial matrix or standard addition were ruled 
out as options. To ensure an accurate quantification, a surrogate calibration method was 
chosen [32]. In this approach, isotope-labelled standards were used as external calibrants 
instead of the authentic reference compounds. However, the detector response of the 
surrogate calibrant had to be the same as for the respective target analyte (parallelism of 
calibration lines). If a significant deviation occurs, as in this work for the target amino acids, a 
response factor correction (see SI, eq. S1) has to be applied. Response factors of uniformly-
13C,15N-labelled amino acids were determined in comparison to authentic amino acids by 
their respective slope ratios (see SI Table S5) and applied to obtain corrected calibration 
functions (eq. 2) (SI Figure S5). 
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Matrix effects are a prime source for inaccurate results in quantitative LC-MS analysis with 
ESI and represent always a considerable challenge, especially in metabolomics [33]. Due to 
sample complexity and elimination of dedicated sample preparation to avoid metabolite 
losses, the accuracy of the results can be negatively influenced by the matrix effects. 
Therefore, matrix effects were estimated by establishing calibration series of surrogate 
calibrants (13C,15N-labelled amino acids) in matrix (HCE cell extract) and in matrix-free (neat) 
solutions using eq. 1. Table 3 summarizes the results for the determined matrix effects. For a 
majority of targeted amino acids, matrix effects are in an acceptable range. However, for a 
small number of targets, there is a significant matrix effects. Hence, it is advisable to perform 
matrix-matched calibration and for this reason a surrogate calibrant approach was selected. 
Deuterated amino acids were used as internal standards (see Table 2). The calibration 
series consisted of 10 different concentrations of 13C,15N-amino acids spiked into untreated 
HCE cell extract samples. The linear range, lower-limit-of-quantification (LLOQ) and upper-
limit-of-quantification (ULOQ) were determined according to FDA guidelines and these are 
summarized in Table 3 along with slope, intercept, and linearity values for each amino acid. 
These guidelines set the following criteria: the S/N ratio should be equal to 10 or higher with 
a precision of 20% and an accuracy of 100 ± 20% for the LLOQ and the ULOQ. The 
concentration levels should be in between the LLOQ and ULOQ and an accuracy of 100 ± 
15% is needed. The linear range should cover two to three orders of magnitude with an R2 of 
>0.99 for all analytes.  
During the validation process intra-day and inter-day precision were determined with eight 
different QC samples, which were composed of 13C,15N-amino acids spiked into untreated 
HCE cell extract samples with deuterated amino acids as internal standards. Nevertheless, 
only three QC samples (QClow, QCmiddle, QChigh; for concentrations see SI Table S6) were 
taken into consideration for assessment. Accuracies (as % recoveries) and precisions (as 
coefficients of variation CV in %) were determined on three different days. All results were 
evaluated based on FDA guidelines with the following criteria: the QC samples should show 
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an accuracy of 100 ± 15 %. Every QC sample was measured eight times and according to 
the guidelines four out of the eight should be within 15% CV. Additionally, the freeze/thaw 
stability of the cell extracts was examined by preparing the same QC samples according to 
FDA guidelines.  
The results of the validation and stability study are summarized in Table S6. Since 
accuracies were between 88 and 115% and precisions <13% CV, the targeted assay was 
found to be suitable for quantitative analysis of amino acids in HCE cell extracts. 
3.4. Application to Human Corneal Epithelial Cell Extracts 
The validity and applicability of the targeted assay was verified by measuring several HCE 
cell extracts (controls and IL treated ones) after 1:10 dilution. The sample injection order was 
randomized and is shown in Table S7. The corresponding quantitative results for amino 
acids are summarized in Table S8. The calculations of the concentrations were based on 
linear calibration functions of 13C,15N-isotopically labelled amino acids, taking the response 
factor correction into account (Table 3). Except for Cys, Gln, Asn, and Asp all proteinogenic 
amino acids were detected in the cell extracts. 
A closer look at the amino acid concentrations as a function of the treatment with different 
ionic liquids (Table S8) reveals clear trends for the classification of the amino acids into the 
same chemical group. For example, the essential aliphatic amino acids Leu, Ile, and Val are 
not much affected by the addition of ionic liquids. Alanine concentrations in the IL-treated 
cells, on the other hand, decrease in comparison to the control samples depending on the 
toxicity of the IL. Similar to alanine, the concentration of glycine decreases the more toxic the 
IL is, except for the two choline-containing ILs. Altered concentrations are found for other 
amino acids as well. This supports the hypothesis of Ruokonen et al. that ILs, e.g. [Ch][Hex], 
interact with the cell membrane and affect the cell metabolism [4].  
Additional information was provided by the untargeted metabolic profiling data. The data 
preprocessing was done with MS-Dial comprising peak spotting, deisotoping, adduct 
annotation, alignment, deconvolution, and identification based on metabolomics data bases 
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described in detail above [25]. Successful identification of several metabolites in HCE cell 
extracts by spectral match in various databases was verified with authentic standards (Table 
4). The tentative metabolites were injected as a standard mixture dissolved in MilliQ water 
and product ion scans were acquired. Retention times and MS/MS spectra of the tentative 
metabolites acquired in the standard solution were compared with the corresponding data 
measured in the HCE cell extracts (Figure S6) and some representative results are shown in 
Figure 4. In case of acetylcholine and oxo-proline more than one peak with the same 
precursor mass was detected in the HCE extract, but the right peak was easily identified 
using the MS/MS spectra. Raw MS/MS spectra of SWATH acquisition often have poor 
spectral quality because they represent composite spectra of several precursors isolated in 
the same Q1 (SWATH) window which are fragmented simultaneously. The composite 
MS/MS spectra of the TOF-MS read out may be difficult to interpret in some cases. However, 
MS-DIAL has implemented a deconvolution tool which provides deconvoluted MS/MS 
spectra of good quality and matches them against database spectra. For example, the raw 
MS/MS spectrum of acetylcholine in the HCE extract (Figure 4D; top panel) is of relatively 
good quality and shows the three main fragments found in the reference spectrum of the 
standard solution (Figure 4C; top panel). Only a minor contaminating ion (m/z 103.9564) is 
present, which was, however, removed in the deconvoluted MS/MS spectrum (Figure 4E; top 
panel). On the other hand, the MS/MS spectrum of adenosine measured in the HCE extract 
shows poor quality (Figure 4D; middle panel). However, the deconvoluted spectrum perfectly 
matches with the MS/MS spectrum of the standard solution and database. The co-
fragmented ions were successfully removed by the deconvolution approach. Hence, efficient 
deconvolution can overcome limited spectral quality of SWATH acquisition. Similarly, the 
MS/MS spectrum of pantothenic acid measured in the cell extract is not a good match with 
the spectrum obtained from the standard solution (Figure 4, bottom; cf. D and C). Again, the 
deconvolution process reestablishes an MS/MS spectrum of sufficient quality for spectral 
matching with standard solutions and MS/MS databases (Figure 4E, bottom). 
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PLS analysis was performed with EC50 values as dependent variables to explore whether 
there is a correlation between the metabolic profiles in IL-treated HCE cells and the toxicity of 
the ILs. Both data sets (Y and X-matrices) were log transformed prior to PLS. Figure 5 shows 
the resultant score plot of the first two principal components. The full statistical data of the 
PLS model is given in SI Table S9. The PLS model shows a good model fit (R2Y(cum) = 0.997 
with 4 principal components PCs) and yields a satisfactory predictive power (Q2(cum) = 0.884 
with 4 PCs). In the score plot the most toxic ionic liquids tributyl(tetradecyl)phosphonium 
acetate ([P14444][OAc]) and tributyl(tetradecyl)phosphonium chloride ([P14444]Cl) are grouped 
together in a cluster that is most distant from the controls. The second most toxic ILs 
tributylmethylphosphonium acetate ([P4441][OAc]) and tributylmethylammonium acetate 
([N4441][OAc]) are also farther away from the controls than the least toxic IL 1,5-
diazabicyclo(4,3,0)non-5-enium acetates ([DBNH][OAc]) and the reference compound N-
methylmorpholine N-oxide (NMMO). The results are confirmed by the heatmap shown in 
Figure 6. It visualizes the relative concentration profiles of target amino acids and other 
identified metabolites according to the IL used for the treatment. Z-score normalization of the 
data was applied. The most significant perturbations can be seen for the two ILs with the 
highest toxicity ([P14444][OAc] and [P14444]Cl). Additionally, [P4441][OAc] shows also significantly 
altered metabolite concentrations. This was partly expected regarding its EC50 value. 
In general, our data suggest that cellular toxicometabolomics profiling of ILs can be a useful 
strategy to classify ILs for their toxicity potential. Already Ruokonen et al. pointed out that the 
used ILs can be separated into three groups based on their toxicity mechanism [4]. ILs, 
which exert toxicity by penetrating into the cell membrane ([P14444][OAc], and [P14444]Cl), ILs 
which affect both the cell membrane and the cell metabolism ([P4441][OAc], and 
[Ch][Hexanoate]), and ILs which only influence cell metabolism ([N4441][OAc], [emim][OAc], 
[DBNH][OAc], [Ch][OAc], and the reference compound NMMO) [4]. The different groups are 
also clearly seen in the LC-MS analysis results in form of grouped ILs in the PLS score plot 
(Figure 5). Therefore, the most harmful ILs are [P4441][OAc], [P14444][OAc], and [P14444]Cl, 





A targeted UHPLC-ESI-MS/MS method for amino acids combined with untargeted metabolic 
profiling in cells after IL treatment was developed and utilized for a preliminary 
toxicometabolomics study. Data independent acquisition using SWATH with variable Q1 
window sizes (narrow Q1 precursor isolation windows for the target amino acids and wider 
Q1 windows for other metabolites) provided comprehensive MS and MS/MS data for 
quantification in either MS or MS/MS mode. The latter was shown to be more sensitive. 
Uniformly 13C,15N-labelled amino acids were used as surrogate calibrants for accurate 
quantification of the target metabolites. PLS analysis revealed a significant correlation 
between the toxicity (as measured by EC50 values) and the metabolic profiles in IL-treated 
HCE cells. 
The results of the targeted and untargeted analysis support the data of Ruokonen et al. [4]. 
The most toxic ILs ([P14444][OAc] and [P14444]Cl) result in different heatmap profiles compared 
to the practically harmless ILs (e.g. [emim][OAc]). Therefore, LC-MS based metabolic 
profiling is a useful strategy in the future for screening the toxicity of ILs. A full 
toxicometabolomics study will be carried out with selected ILs implementing a sufficient 
number of biological replicates and focusing on a wider metabolite coverage (positive and 
negative ion mode; hydrophilic and lipophilic metabolites) to allow derivation of meaningful 
interpretation of the toxicometabolic regulations. 
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Figure 1: Used ionic liquids (ILs) with corresponding concentrations used for IL treatment; 
Molar mass of the IL and EC50-value ± STD 
Figure 2: Chromatographic separation of a standard solution of 20 proteinogenic amino 
acids in HILIC mode using a BEH Amide column (10 µg/mL) and the optimized SWATH 2.0 
method. The m/z values of precursor and fragment ions (bold) are listed on the right side. For 
the EIC chromatograms fragment masses were used. 
Figure 3: Targeted analysis of Tryptophan (precursor: m/z 205.097 and main fragment: m/z 
146.060) in HCE cell extracts (QC sample). (A) Peak group chromatograms measured by 
SWATH 2.0, the extracted fragment mass was m/z 146.06 with an extraction window of +/- 5 
mDa; (B) MS/MS spectrum by SWATH 2.0 measured in HCE cell extracts; (C) MS/MS 
spectrum of tryptophan in neat standard solution measured by MRMHR; (D) deconvoluted 
MS/MS spectrum (blue) matched against database spectrum (red). 
Figure 4: Examples of identified metabolites from untargeted analysis of HCE cell extracts. 
(A) EIC MS/MS chromatogram (Acetylcholine: m/z 146.1153, Adenosine: m/z 268.1030 and 
Pantothenic acid: m/z 220.1168; m/z values were used for EIC generation in A and B) of 
standard solution with an extraction window of +/- 5 mDa; (B) EIC MS/MS chromatogram of 
HCE extract with an extraction window of +/- 5 mDa; (C) MS/MS spectrum from standard 
solution; (D) MS/MS spectrum from HCE extract; (E) deconvoluted MS/MS spectrum from 
the HCE extract (blue) matched against database spectrum (red). 
Figure 5: Multivariate data analysis (PLS) showing the correlation of toxicity data (log EC50 
as dependent variable) and metabolic profile (all molecular features log transformed as 
independent variables): Score plot of 1st and 2nd principal component (for statistical 
parameters see SI Table S9). 
Figure 6: Heatmap showing perturbations of identified features by ILs as compared to 
untreated controls of HCE cells; intensities were z-score normalized and the samples 




Table 1: Overview of the MS-settings used for SWATH acquisition mode with variable Q1 
window widths; in bold are the “targeted” Q1 windows 
Experiment 
number 
Q1 window range 
[m/z] 
target amino acid; 
precursor mass [m/z]; 






SWATH with variable Q1 window width 
0 30 - 1000 TOF MS 10 30 
1 30 - 75 
 
10 20 
2 75 - 80 Gly; 76.0393; - 5 20 
3 80 - 89 
 
10 20 
4 89 - 95 Ala;90.0547;44.0533 21 10 
5 95 - 105 
 
10 20 
6 105 - 111 Ser;106.0499;60.0462 20 10 
7 111 - 115 
 
10 30 
8 115 - 117 Pro;116.0706;70.0685 20 20 
9 117 - 119 Val;118.0863;72.0833 16 20 
10 119 - 121 Thr;120.0655;74.0618 17 30 
11 121 - 123 Cys;122.0270;76.0236 20 20 
12 123 - 131 
 
17 30 
13 131 - 135 
Leu/Ile;132.1019;86.0979 
12 30 Asn;133.0608;74.0258 
Asp;134.0448;74.0260 
14 135 - 146 
 
14 30 
15 146 - 149 
Gln;147.0764;84.0457 
23 15 Lys;147.1128;84.0822 
Glu;148.0613;84.0450 
16 149 - 151 Met;150.0583;104.0530 15 60 
17 151 - 155 
 
25 20 
18 155 - 157 His;156.0768;110.0710 21 40 
19 157 - 164 
 
10 30 
20 164 - 167 Phe;166.0863;120.0810 23 15 
21 167 - 174 
 
23 15 
22 174 - 177 Arg;175.1190;70.0679 35 50 
23 177 - 181 
 
21 10 
24 181 - 183 Tyr;182.0812;136.0752 22 20 
25 183 - 204 
 
30 30 
26 204 - 206 Trp;205.0972;146.0598 25 10 







Table 2: Comparison of S/N ratios (as calculated with PeakView) for EICs of precursor ions 
from TOF-MS scans, of precursor ions from MS/MS experiment (i.e. corresponding SWATH 
window), and of fragment ions from MS/MS experiment (SWATH window) as measured in 
HCE cell extract (QC sample) 




















Gly 76.0393 - d-Tyr 43 1407 - 
L-Ala 90.0547 44.0533 d-Tyr 175 13 418 
L-Ser 106.0499 60.0462 d-Tyr 33 10 184 
L-Proc 116.0706 70.0685 d-Tyr 2962 5286 3439 
L-Val 118.0863 72.0800 d-Val 224 336 1069 
L-Thr 120.0655 74.0618 d-Tyr 379 215 1819 
L-Cys 122.0270 76.0236 d-Tyr -a -a -a 
L-Leu 132.1019 86.0979 d-Val 133 114 1232 
L-Ile 132.1019 86.0979/(69.0727) d-Val 122 140 2671/(111) 
L-Asn 133.0608 88.0395 d-Tyr -a -a -a 
L-Asp 134.0448 88.0394 d-Lys -a -a -a 
L-Gln 147.0764 84.0457 d-Tyr -a -a -a 
L-Lys 147.1128 84.0822 d-Lys 46 6 297 
L-Glu 148.0613 84.0450 d-Tyr 246 36 1017 
L-Met 150.0583 104.0527 d-Val 297 292 971 
L-His 156.0768 110.0714 d-Lys 111 90 849 
L-Phe 166.0863 120.0814 d-Val 592 96 6762 
L-Arg 175.1190 70.0679 d-Lys 200 - 1108 
L-Tyr 182.0812 136.0752 d-Tyr 318 41 1579 
L-Trp 205.0972 146.0598 d-Val 43 - 645 
  
      
a not detected in HCE cell extract samples 
b assignment based on retention times of the amino acid and the 
corresponding internal standard  
c very high abundant in HCE cell extracts, therefore end of linear 
range (ULOQ) is easily reached   
in bold: most sensitive signal with highest S/N ratio used for quantitation (except Pro for 





























































































































































































































































































28 22.7 85 
13C,15N isotopically labelled amino acids (Eurisotop Std) 
were used as surrogate calibrants 
 
The linear range is from LLOQ to ULOQ 
      The amino acids Trp, Asn and Gln were not included in the 13C,15N isotopically labelled 
amino acid standard mixture. Asn and Gln were therefore not calibrated but were also not 
detected in the HCE cell extracts at all. Trp was calibrated based on 13C,15N-Lys as surrogate 
calibrant (see Table S5) 
a Cysteine was detected as the dimer cystine with m/z 124.02  in the SWATH  window of m/z 



































































































































































































































101.0609; 100.0770; 83.0508; 




















101.0609; 100.0770; 83.0508; 
59.0755; 58.0684; 56.0530; 
55.0579 






























 UHPLC-ESI-MS/MS method for quantitative amino acids analysis in cells developed 
 Data-independent acquisition allows simultaneous untargeted metabolic profiling 
 PLS reveals a correlation between metabolic profiles and toxicity of ILs 
 The most toxic ILs tested were [P4441][OAc], [P14444][OAc] and [P14444]Cl 
 LC-MS metabolic profiling seems to be a useful strategy to classify the toxicity of ILs 
 
 
